Monday 26 March 2018

Reuters Health Report: Roche's Tecentriq cocktail adds to lung cancer survival success

Roche's Tecentriq cocktail adds to lung cancer survival success

ZURICH (Reuters) - Roche's Tecentriq immunotherapy combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss company said as it seeks an edge on Merck and Bristol-Myers Squibb.

Singapore pharma on recovery path after worst output in decades

SINGAPORE (Reuters) - Singapore's pharmaceuticals business, among the pillars of the city-state's manufacturing sector, is set to return to strength this year as big global drugmakers ramp up output and advance automation at their production sites across the country.

Israel to launch Big Data health project

JERUSALEM (Reuters) - Israel will invest nearly 1 billion shekels ($287 million) in a project to make data about the state of health of its population available to researchers and private companies, Prime Minister Benjamin Netanyahu said on Sunday.

Drug shortages cripple Angola's health service

OKANAUTONI, Angola (Reuters) - Apart from a few packs of medicine and plastic jars, the shelves at the Okanautoni health center in southern Angola are bare and lack basic drugs for saving lives.

FDA moves to limit ingredients for bulk drug compounding

BOSTON (Reuters) - The U.S. Food and Drug Administration on Friday took steps to restrict what pharmaceutical ingredients large compounding pharmacies can use to manufacture drugs in bulk that do not go through the agency's approval processes.

Trump says will sue drug companies over opioids

WASHINGTON (Reuters) - U.S. President Donald Trump on Friday said his administration will be suing some drug companies as part of its fight against the opioid drug crisis, without giving more detail.

Pfizer's quit-smoking Chantix fails study in adolescent smokers

(Reuters) - Pfizer Inc said on Friday its study to test safety and effectiveness of its anti-smoking treatment Chantix in adolescent smokers failed to meet the main goal.

EMA panel recommends against Portola's clot prevention drug

(Reuters) - A panel of European Medicines Agency on Friday recommended against granting marketing approval to Portola Pharmaceuticals Inc's oral blood thinner, saying the benefits of the drug did not outweigh risks.

Top-quality nursing homes harder to access with mental health issues

(Reuters Health) - Even people with common and often treatable mental health problems like depression and anxiety may have a harder time than patients without these diagnoses getting admitted to a high-quality nursing home, a U.S. study suggests.

Obesity, overweight tied to shorter life, more years with heart disease

(Reuters Health) - Obese people have shorter lives and even those who are just overweight spend more years living with heart disease than individuals who are a healthy weight, a U.S. study suggests.

Related Videos

Wanna find Nemo? You may need SoFi the robotic fish

From plastic waste to fashion statement

Read Reuters on the go

Download the free Reuters News app today for breaking news, analysis and market data from the world's most trusted news organization.

Get the app